Court ka verdict: 'Otide' pe laga rok!
Aur Sun Pharma ne Bombay High Court mein jeet daag di hai! Court ne United Biotech ko saaf saaf keh diya hai ki woh Sun Pharma ke 'Octride' brand se milte-julte 'Otide' naam ka istemaal bilkul nahi kar sakte. Yeh Sun Pharma ke liye ek badi victory hai, jisse unka brand aur market mein good will secure hoga. India ki sabse badi pharma company, jiska market cap ₹2.5 Trillion hai aur P/E ratio lagbhag 45 ke aas-paas hai, apne intellectual property ko defend karne mein kaafi active rehti hai.
'Octride' vs 'Otide' ka funda kya hai?
Yeh poori situation Octreotide Acetate drugs ko lekar thi. Sun Pharma ka 'Octride' toh 1999 se market mein hai, matlab kab se! Wahi United Biotech ka 'Otide' 2006 se istemaal mein aa raha hai. Court ne is baat par focus kiya ki Sun Pharma kaafi pehle se market mein hai, aur agar koi similar naam wala competitor aa gaya toh customers confused ho jayenge aur Sun Pharma ki reputation ko nuksaan pahunchega.
Aage kya?
Is win se Sun Pharma ko immediate relief mil gayi hai, par pharma sector mein competition toh hamesha tight rehti hai. Choti companies jaise United Biotech ko bade players ke saath compete karna tough hota hai. Sun Pharma apne scale aur legal strength ka use karke aise mamlon ko handle kar leti hai. Apne branded products ki value maintain karna aur unhe protect karna Sun Pharma ki core strategy ka ek important hissa hai.
